Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-10

Clinical Trial Update: The Effects of Dexamethasone Administration on Jaundice Following Liver Resection [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the effects of dexamethasone administration on jaundice after liver resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Liver Dysfunction, Hepatectomy | Phase 2, Phase 3 | Status: COMPLETED